Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.72 is 20% above its 5-year average of -2.16, near the high end of its 5-year range (-4.60–-1.41).
As of the fiscal period ended Wednesday, December 31, 2025. 42.76% above its 12-month average of -3.00.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 18 quarters.
EARNINGS PER SHARE (EPS)
-1.72
EARNINGS PER SHARE (EPS) AVG TTM
-3.00
EARNINGS PER SHARE (EPS) AVG 3Y
-2.43
EARNINGS PER SHARE (EPS) AVG 5Y
-2.16
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+42.76%
CURRENT VS 3Y AVG
+29.15%
CURRENT VS 5Y AVG
+20.31%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Tempus AI, Inc.
Market Cap
$7.47B
Earnings Per Share (EPS)
-1.72
TTM Avg
-3.00
3Y Avg
-2.43
5Y Avg
-2.16
Market Cap
$7.31B
Earnings Per Share (EPS)
-0.54
TTM Avg
-0.79
3Y Avg
-1.41
5Y Avg
-1.76
Market Cap
$8.50B
Earnings Per Share (EPS)
6.07
TTM Avg
-18.74
3Y Avg
-45.28
5Y Avg
14.90
Market Cap
$6.27B
Earnings Per Share (EPS)
-0.09
TTM Avg
0.57
3Y Avg
0.18
5Y Avg
-0.06
Market Cap
$9.74B
Earnings Per Share (EPS)
3.31
TTM Avg
3.18
3Y Avg
3.37
5Y Avg
3.47
Market Cap
$9.75B
Earnings Per Share (EPS)
23.83
TTM Avg
20.29
3Y Avg
15.04
5Y Avg
13.87
Market Cap
$10.31B
Earnings Per Share (EPS)
0.19
TTM Avg
14.72
3Y Avg
15.46
5Y Avg
14.11
Market Cap
$10.37B
Earnings Per Share (EPS)
-7.29
TTM Avg
-6.79
3Y Avg
-1.56
5Y Avg
-0.26
Market Cap
$10.91B
Earnings Per Share (EPS)
-3.76
TTM Avg
-1.35
3Y Avg
4.03
5Y Avg
5.21
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tempus AI, Inc. (TEM) | $7.47B | -1.72 | -3.00 | -2.43 | -2.16 |
| Oscar Health, Inc. (OSCR)vs › | $7.31B | -0.54 | -0.79 | -1.41 | -1.76 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.50B | 6.07 | -18.74 | -45.28 | 14.90 |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.27B | -0.09 | 0.57 | 0.18 | -0.06 |
| Henry Schein, Inc. (HSIC)vs › | $9.74B | 3.31 | 3.18 | 3.37 | 3.47 |
| Universal Health Services, Inc. (UHS)vs › | $9.75B | 23.83 | 20.29 | 15.04 | 13.87 |
| Molina Healthcare, Inc. (MOH)vs › | $10.31B | 0.19 | 14.72 | 15.46 | 14.11 |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -7.29 | -6.79 | -1.56 | -0.26 |
| Charles River Laboratories International, Inc. (CRL)vs › | $10.91B | -3.76 | -1.35 | 4.03 | 5.21 |
| Bio-Techne Corporation (TECH)vs › | $11.21B | 0.69 | 0.77 | 1.27 | 1.25 |
Trailing EPS (TTM)
$-1.72
Forward EPS (Est.)
$-0.34
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.41 |
| 2024-12-31 | -4.60 |
| 2023-12-31 | -1.73 |
| 2022-12-31 | -1.97 |
| 2021-12-31 | -1.75 |
| 2020-12-31 | -1.49 |
| 2019-12-31 | -0.92 |
